Discover the world's scientific knowledge

With 160+ million publication pages, 25+ million researchers and 1+ million questions, this is where everyone can access science

You can use AND, OR, NOT, "" and () to specify your search.

PublicationsAuthorsQuestions
Efficacy and Safety of Zanubrutinib in IgA-secerning Lymphoplasmacytic Lymphoma
Article
  • Jan 2022
  • DOI: 10.26502/jcsct.5079151
  • Giulia Zamprogna
    Giulia Zamprogna
  • Anna Maria Frustaci
    Anna Maria Frustaci
  • Marina Deodato
    Marina Deodato
  • Heather Allewelt
    Heather Allewelt
  • Dirk Weber
    Dirk Weber
Safety and efficacy of zanubrutinib in relapsed/refractory marginal zone lymphoma: final analysis of the MAGNOLIA study
Article
  • Sep 2023
  • DOI: 10.1182/bloodadvances.2023010668
  • ISBN: 2473-9537
  • Stephen Opat
    Stephen Opat
  • Alessandra Tedeschi
    Alessandra Tedeschi
  • Bei Hu
    Bei Hu
  • Kim M. Linton
    Kim M. Linton
  • Pamela McKay
    Pamela McKay
Indirect comparisons of efficacy of zanubrutinib versus orelabrutinib in patients with relapsed or refractory chronic lymphocytic leukemia/small lymphocytic lymphoma or relapsed or refractory mantle cell lymphoma
Article
  • Jul 2023
  • DOI: 10.1007/s10637-023-01376-1
  • ISBN: 1573-0646
  • Yuqin Song
    Yuqin Song
  • Keshu Zhou
    Keshu Zhou
  • Jianda Hu
    Jianda Hu
  • Shenmiao Yang
    Shenmiao Yang
  • Dehui Zou
    Dehui Zou
Preview image for Zanubrutinib in relapsed/refractory mantle cell lymphoma: long-term efficacy and safety results from a phase 2 study
Source
Zanubrutinib in relapsed/refractory mantle cell lymphoma: long-term efficacy and safety results from a phase 2 study
Article
  • Mar 2022
  • DOI: 10.1182/blood.2021014162
  • ISBN: 0006-4971
  • Yuqin Song
    Yuqin Song
  • Keshu Zhou
    Keshu Zhou
  • De-Hui Zou
    De-Hui Zou
  • Jianfeng Zhou
    Jianfeng Zhou
  • Jianda Hu
    Jianda Hu
Lymphoplasmacytic Lymphoma with IgA Paraproteinemia
Article
  • Aug 2015
  • DOI: 10.7754/Clin.Lab.2015.150117
  • ISBN: 1433-6510
  • Jing Guan
    Jing Guan
  • Fang Fang
    Fang Fang
  • Zonghong Shao
    Zonghong Shao
MYD88L265P mutated IgA lymphoplasmacytic lymphoma
Article
  • May 2019
  • DOI: 10.1111/his.13921
  • ISBN: 0309-0167
  • Marcela Urquieta Lam
    Marcela Urquieta Lam
  • Alejandra Moreno Aguirre
    Alejandra Moreno Aguirre
  • Ainara Gonzalez Pereña
    Ainara Gonzalez Pereña
  • Sonia González de Villambrosia
    Sonia González de Villambrosia
  • Javier Nuñez Cespedes
    Javier Nuñez Cespedes
Preview image for Zanubrutinib plus salvage chemotherapy for relapsed or refractory diffuse large B-cell lymphoma
Source
Zanubrutinib plus salvage chemotherapy for relapsed or refractory diffuse large B-cell lymphoma
Article
  • Nov 2022
  • DOI: 10.3389/fimmu.2022.1015081
  • ISBN: 1664-3224
  • Xianggui Yuan
    Xianggui Yuan
  • Xian Li
    Xian Li
  • Yurong Huang
    Yurong Huang
  • Xueli Jin
    Xueli Jin
  • Hui Liu
    Hui Liu
Preliminary Safety and Efficacy Data from Patients (Pts) with Relapsed/Refractory (R/R) B-Cell Malignancies Treated with the Novel B-Cell Lymphoma 2 (BCL2) Inhibitor BGB-11417 in Monotherapy or in Combination with Zanubrutinib
Article
  • Nov 2021
  • DOI: 10.1182/blood-2021-148451
  • ISBN: 0006-4971
  • Constantine S. Tam
    Constantine S. Tam
  • Emma Verner
    Emma Verner
  • Masa Lasica
    Masa Lasica
  • Alejandro Arbelaez
    Alejandro Arbelaez
  • Peter J. Browett
    Peter J. Browett
Efficacy and safety of zanubrutinib plus R-CHOP in treatment of non-GCB DLBCL with extranodal involvement
Article
  • Aug 2023
  • DOI: 10.3389/fimmu.2023.1219167
  • ISBN: 1664-3224
  • Hongzhi Geng
    Hongzhi Geng
  • Sixun Jia
    Sixun Jia
  • Ying Zhang
    Ying Zhang
  • Jiaqi Li
    Jiaqi Li
  • Qin Yang
    Qin Yang
MAHOGANY: A phase 3 trial of zanubrutinib plus anti-CD20 antibodies vs lenalidomide plus rituximab in patients with relapsed or refractory follicular or marginal zone lymphoma.
Article
  • Jun 2023
  • DOI: 10.1200/JCO.2023.41.16_suppl.TPS7590
  • ISBN: 0732-183X
  • Loretta J. Nastoupil
    Loretta J. Nastoupil
  • Yuqin Song
    Yuqin Song
  • Laurie H. Sehn
    Laurie H. Sehn
  • Clémentine Sarkozy
    Clémentine Sarkozy
  • Pier Luigi Zinzani
    Pier Luigi Zinzani
1
2
3
4
5
10
App Store
Get it on Google Play
Company
About us
News
Careers
Support
Help Center
Business solutions
Advertising
Recruiting
© 2008-2023 ResearchGate GmbH. All rights reserved.
  • Terms
  • Privacy
  • Copyright
  • Imprint
Join for free
Log in